EXACT SCIENCES CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 8 rows in 2013. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2013-09-20: Reporting owner CRAWFORD SALLY; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2013-09-20: Reporting owner CRAWFORD SALLY; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2013-07-16: Reporting owner CRAWFORD SALLY; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2013-04-29: Reporting owner Carey Thomas D.; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2013-09-20 | CRAWFORD SALLY Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,000 0 owned after | $4.99 exercise price | 2013-09-24 | |
| 2013-09-20 | CRAWFORD SALLY Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 5,000 owned after | $2.24 exercise price | 2013-09-24 | |
| 2013-07-16 | CRAWFORD SALLY Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,000 0 owned after | $13.18 exercise price | 2013-07-17 | |
| 2013-04-29 | Carey Thomas D. Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,620 15,620 owned after | $9.24 exercise price | 2013-05-01 | |
| 2013-02-22 | Stoltenberg Laura S Officer (Chief Commercial Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +39,500 39,500 owned after | $10.82 exercise price | 2013-02-25 | |
| 2013-02-22 | LIDGARD GRAHAM PETER Officer (Sr. VP, Chief Science Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +39,500 39,500 owned after | $10.82 exercise price | 2013-02-25 | |
| 2013-02-22 | ARORA MANEESH Officer (COO and CFO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +39,500 39,500 owned after | $10.82 exercise price | 2013-02-25 | |
| 2013-02-22 | Conroy Kevin T Director, Officer (President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +106,000 106,000 owned after | $10.82 exercise price | 2013-02-25 |